This search combines search strings from the content search (i.e. "Full Text", "Author", "Title", "Abstract", or "Keywords") with "Article Type" and "Publication Date Range" using the AND operator.
Beilstein J. Nanotechnol. 2019, 10, 2062–2072, doi:10.3762/bjnano.10.201
Figure 1: Resulting particle diameters and loading efficiencies for different nanoparticle formulations using...
Figure 2: SEM images of nanoparticles using emulsion diffusion (ED) or solvent displacement (SD) preparation ...
Figure 3: Doxorubicin (Dox) release profiles over 24 h for all nanoparticle systems using (A) emulsion diffus...
Figure 4: Doxorubicin (Dox) drug load and loading efficiency for PLGA nanoparticles (NPs) prepared using a PV...
Figure 5: (A) Drug load and loading efficiencies as well as (B) particle diameter and PDI for different amoun...
Figure 6: Release profiles of doxorubicin from PLGA nanoparticles prepared using an unmodified PVA solution a...
Figure 7: Doxorubicin concentrations that reduce neuroblastoma cell viability by 50% (IC50) when administered...
Figure 8: Doxorubicin concentrations that reduce UKF-NB-3rVCR1 viability by 50% (IC50) in the absence or pres...
Beilstein J. Nanotechnol. 2019, 10, 1707–1715, doi:10.3762/bjnano.10.166
Figure 1: SEM confirmed the spherical shape and narrow size distribution of doxorubicin-loaded HSA (100%) nan...
Figure 2: Doxorubicin sensitivity of UKF-NB-3, its doxorubicin-adapted sub-line UKF-NB-3rDOX20 and its vincri...
Figure 3: Effects of doxorubicin (Dox) applied as a solution or incorporated into human serum albumin (HSA) n...
Figure 4: Fold sensitisation to doxorubicin by doxorubicin-bound nanoparticles (NPs). Values are expressed as...
Figure 5: Doxorubicin (Dox) concentrations that reduce neuroblastoma cell viability by 50% (IC50) in the pres...
Beilstein J. Nanotechnol. 2019, 10, 1002–1015, doi:10.3762/bjnano.10.101
Figure 1: SEM confirmed the spherical shape of the PLGA NPs and the smoothness of the surface.
Figure 2: Adsorption of serum proteins on PLGA NPs (n ≥ 3; mean ± SD). (A) Quantification of the total amount...
Figure 3: One-dimensional SDS-PAGE of adsorbed serum proteins obtained from the corona of PLGA NPs following ...
Figure 4: Surface charge evolution of PLGA NPs after exposure to different amounts of serum in the incubation...
Figure 5: Semiquantitative densitometry analysis of the eight highlighted protein bands from Figure 3B (mean ± SD; n =...
Figure 6: Bioinformatic classification of proteins identified in the corona of PLGA NPs after exposure to FBS...
Figure 7: Time-dependent cell interaction of PLGA NPs with HepG2 cells in the absence or presence of a prefor...
Figure 8: Visualization of the cell interaction of PLGA NPs after 6 h with HepG2 cells in the absence (C) or ...